Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
doxorubicin (Doxil) (1 trial)
etoposide (vepesid) (1 trial)
ifosfamide (ifex) (1 trial)
naltrexone (revia) (1 trial)
prednisone (meticorten) (1 trial)
rituximab (rituxan) (1 trial)
sargramostim (leukine) (1 trial)
urea (1 trial)
vincristine (oncovin) (1 trial)
inotuzumab ozogamicin (besponsa) (1 trial)
flurbiprofen (ansaid) (1 trial)
Burkitt Lymphoma (Phase 4)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 4)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Mediastinal Neoplasms (Phase 4)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)
Trials (3 total)
Trial APIs (13 total)